Based on a patient’s lymphocyte count (1.83 × 109/L), alanine transaminase level (8.9 U/L), triglyceride level (1.39 mmol/L), and body mass index (33.9 kg/m2), the predicted probability of the development of NAFLD was 0.977, indicating that this patient has a 97.7% chance of having NAFLD. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.